"synopsis" may belong to another edition of this title.
""Deadly Monopolies" explores contentious issues in modern biomedical research that have been aggravated by the field's commercial emphasis.....Though she is not the first to raise many of these concerns, Washington offers an overarching framework that enables readers to see connections that are often obscured. The book's brilliance lies in the compassionately told narratives of individuals whose lives have been affected by the increasing corporate control of scientific research. Rather than simply writing another book about biomedical wrongdoing, Washington with her journalistic approach provides a more humane account of the problems tied to the for-profit nature of today's research industry. In doing this, Washington accomplishes what has thus far escaped previous authors. She makes the case for a broader "political "consciousness of science and technology....This is precisely the conversation an important book starts in order to challenge readers to see the world differently so that they connect the disparate dots. "Deadly Monopolies" is an extraordinary achievement in this and many other regards."--Osagie K. Obasogie, "The American Prospect"
"A searing look at the medical-industrial complex and its ability to patent genes and other biological products, resulting in an opportunistic and powerful pharmaceutical industry that often ignores the most pressing global-health issues in order to make a profit.
National Book Critics Circle Award winner Washington ("Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present," 2007, etc.) begins with the controversial 1980 Bayh-Dole Act, which allowed the commercialization of medical inventions based on government-funded patents, including those on living things. As a result, an unprecedented collusion between universities, researchers and private pharmaceutical and biotechnology companies spawned an era i
Praise for "Deadly Monopolies"
"Harriet Washington shines her relentless torch into the darkest corners of Big Pharma with courage, dedication and accuracy."
--John le Carre
"Important. . . . Humane. . . . An extraordinary achievement."
--"The American Prospect"
"An important and compelling book."
--Marcia Angell, M.D., author of "The Truth About the Drug Companies "
" "
"A searing look at the medical-industrial complex and its ability to patent genes and other biological products. . . . [Washington] adeptly details the wide-ranging repercussions of this monopolistic research model and recounts chilling anecdotes that reveal a pattern of shady practices by biotech and pharma companies. . . . The author clearly presents data to elucidate these complex issues, and cogently argues that there are opportunities to reinstate transparency, collaboration and altruism in drug development and disbursement. A gripping, revelatory account."
--"Kirkus Reviews" (starred review)
""Deadly Monopolies" explores contentious issues in modern biomedical research that have been aggravated by the field's commercial emphasis. . . . Washington offers an overarching framework that enables readers to see connections that are often obscured. The book's brilliance lies in the compassionately told narratives of individuals whose lives have been affected by the increasing corporate control of scientific research."
--"The American Prospect"
"Harriet Washington has written an important and compelling book. She shows how recent changes in patent law have caused drug prices to soar, while reducing innovation by drug companies to near-zero. Well-documented, yet highly readable, the book paints a vivid picture of an industry that now exploits monopoly rights to patients' genes, and relies on taxpayer-funded NIH research for its few novel and important drugs--even as it turns out an endless stream of trivial variations of top-selling old drug
Praise for Harriet A. Washington's "Deadly Monopolies"
"Important. . . . Humane. . . . An extraordinary achievement. . . . "Deadly Monopolies" explores contentious issues in modern biomedical research that have been aggravated by the field's commercial emphasis. . . . Washington offers an overarching framework that enables readers to see connections that are often obscured. The book's brilliance lies in the compassionately told narratives of individuals whose lives have been affected by the increasing corporate control of scientific research."
--"The American Prospect"
"Harriet Washington shines her relentless torch into the darkest corners of Big Pharma with courage, dedication and accuracy."
--John le Carre
"Harriet Washington has written an important and compelling book. She shows how recent changes in patent law have caused drug prices to soar, while reducing innovation by drug companies to near-zero. Well-documented, yet highly readable, the book paints a vivid picture of an industry that now exploits monopoly rights to patients' genes, and relies on taxpayer-funded NIH research for its few novel and important drugs--even as it turns out an endless stream of trivial variations of top-selling old drugs."
--Marcia Angell, M.D., author of "The Truth About the Drug Companies "and former editor of the "New England Journal of Medicine"
"Big Pharma is not going to like "Deadly Monopolies" one bit, but you probably will--especially if, like most Americans, you're finding the co-pay on your drugs too much to handle. Washington correctly reminds us that, as hard as high drug costs are in the USA, they are lethal for the world's poor. Brava Harriet Washington!"
--Laurie Garrett, Pulitzer Prize-winning writer and author of "I Heard the Sirens Scream: How Americans Responded to the 9/11 and Anthrax Attacks
"
"Patents, we're repeatedly told, are crucial to fostering innovation. "Deadly Monopolies" reveals how the privatiz
Praise for Harriet A. Washington'sDeadly Monopolies
Important. . . . Humane. . . . An extraordinary achievement. . . . Deadly Monopolies explores contentious issues in modern biomedical research that have been aggravated by the field s commercial emphasis. . . . Washington offers an overarching framework that enables readers to see connections that are often obscured. The book s brilliance lies in the compassionately told narratives of individuals whose lives have been affected by the increasing corporate control of scientific research.
The American Prospect
Harriet Washington shines her relentless torch into the darkest corners of Big Pharma with courage, dedication and accuracy.
John le Carre
Harriet Washington has written an important and compelling book. She shows how recent changes in patent law have caused drug prices to soar, while reducing innovation by drug companies to near-zero. Well-documented, yet highly readable, the book paints a vivid picture of an industry that now exploits monopoly rights to patients genes, and relies on taxpayer-funded NIH research for its few novel and important drugs even as it turns out an endless stream of trivial variations of top-selling old drugs.
Marcia Angell, M.D., author of The Truth About the Drug Companies and former editor of the New England Journal of Medicine
Big Pharma is not going to like Deadly Monopolies one bit, but you probably will especially if, like most Americans, you re finding the co-pay on your drugs too much to handle. Washington correctly reminds us that, as hard as high drug costs are in the USA, they are lethal for the world s poor. Brava Harriet Washington!
Laurie Garrett, Pulitzer Prize-winning writer and author of I Heard the Sirens Scream: How Americans Responded to the 9/11 and Anthrax Attacks
Patents, we re repeatedly told, are crucial to fostering innovation. Deadly Monopolies reveals how the privatization of medical science is retarding research, putting patients at risk, and making what cures we have exorbitantly expensive. This book is a meticulously documented expose of what s gone wrong with our medical innovation system, and a roadmap for change.
Merrill Goozner, author of The $800 Million Pill: The Truth Behind The Cost of New Drugs
[Washington] adeptly details the wide-ranging repercussions ofthis monopolistic research model andrecounts chilling anecdotes that reveal a pattern of shady practices by biotech and pharma companies. . . . The author clearly presents data to elucidate these complexissues, and cogently argues that there are opportunities to reinstate transparency, collaboration and altruism in drug development and disbursement. A gripping, revelatory account.
Kirkus Reviews (starred review)
Harriet A. Washington is the author of Medical Apartheid, which won a National Book Critics Circle Award, the 2007 PEN Oakland Award, and the 2007 American Library Association Black Caucus Nonfiction Award. She has been a fellow in medical ethics at the Harvard Medical School, a senior research scholar at the National Center for Bioethics at Tuskegee University, a fellow at the Harvard School of Public Health, and the recipient of a John S. Knight Fellowship at Stanford University.
"About this title" may belong to another edition of this title.
Shipping:
£ 3.38
Within U.S.A.
Book Description Hardcover. Condition: new. New Copy. Customer Service Guaranteed. Seller Inventory # think0385528922
Book Description Condition: new. Seller Inventory # FrontCover0385528922
Book Description Hardcover. Condition: new. New. Seller Inventory # Wizard0385528922
Book Description Hardcover. Condition: New. Seller Inventory # Abebooks71936
Book Description Hardcover. Condition: new. Buy for Great customer experience. Seller Inventory # GoldenDragon0385528922
Book Description Condition: New. New. In shrink wrap. Looks like an interesting title! 1.6. Seller Inventory # Q-0385528922
Book Description Condition: new. 1. Book is in NEW condition. Satisfaction Guaranteed! Fast Customer Service!!. Seller Inventory # PSN0385528922
Book Description Condition: new. Seller Inventory # Hafa_fresh_0385528922
Book Description Condition: new. Seller Inventory # newMercantile_0385528922
Book Description Hardcover. Condition: new. New. Fast Shipping and good customer service. Seller Inventory # Holz_New_0385528922